Prediction: Pfizer Will Beat the Market in Five Years
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
This list highlights altcoins with clear real-world use cases and tangible value, helping readers prioritize projects with practical impact.
24,805 articlesPfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
SpaceX exploded onto the public markets, and the initial gains grabbed headlines. Two veteran analysts share what the...
Chart Industries just delivered a sweeping earnings milestone, but a sizable investor trimmed a multi-million dollar ...
Lawmakers and regulators weigh a $1.7 billion compensation fund to settle Trump’s suit with $1.7 against the IRS, a m...
A new NVIDIA-backed player has stepped into the high-growth AI photonics space, challenging traditional data-center b...
Sea Limited entertained investors with strong earnings yet faced a dramatic intraday drop driven by rising fintech co...
SoundHound AI reported its sixth consecutive earnings beat as revenue and AI platform demand accelerate. The LivePers...
Investing in AI stocks can feel like a fast-moving target. This article breaks down whether penguin solutions next st...
As the world ages, demand for life-saving medical devices grows. This article breaks down three pragmatic reasons why...
This article dives into exagen (XGN) 2026 earnings, unpacking Q1 results, business momentum, and the path to full-yea...
This year brought a sharp retreat in Accenture’s stock. The drop isn’t just a price move—it's a signal. This guide br...
A hedge fund quietly pulled the plug on a sizable Cinemark stake after a sharp stock decline. The move, disclosed in ...